prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumB, FINAL DIAGNOSIS: PART 1: LYMPH NODE, RIGHT AXILLARY SENTINEL #1, BIOPSY AND FROZEN SECTION -. ONE LYMPH NODE, FREE OF TUMOR (0/1). PART 2: LYMPH NODE, RIGHT AXILLARY SENTINEL #2, BIOPSY AND FROZEN SECTION -. MICROMETASTATIC ADENOCARCINOMA INVOLVING ONE OUT OF TWO LYMPH NODES (1/2), UP TO 1.5 MM (2. FS2) (see comment). PART 3; BREAST. RIGHT, TOTAL MASTECTOMY -. A. INFILTRATING DUCTAL CARCINOMA. B. THE TUMOR SIZE IS 2.7 X 2.5 X 2.4 CM. C. NOTTINGHAM SCORE IS 9/9 (TUBULES 3, NUCLEAR 3, MITOSES 3). D. EXTENSIVE LYMPHOVASCULAR INVASION IS PRESENT. E. DUCTAL CARCINOMA IN-SITU, SOLID AND CRIBRIFORM TYPES, NUCLEAR GRADE 3, WITH. COMEDONECROSIS, ASSOCIATED MICROCALCIFICATION AND RETROGRADE CANCERIZATION OF. LOBULES, PRESENTING ABOUT 5% OF TUMOR VOLUME. F. DUCTAL CARCINOMA IN-SITU IS PRESENT ADMIXED AND OUTSIDE OF INVASIVE TUMOR. G. MARGINS OF RESECTION ARE FREE OF TUMOR. H. NIPPLE, NO TUMOR IS SEEN. I. SKIN, NO TUMOR IS SEEN. J. CHANGES CONSISTENT WITH PREVIOUS BIOPSY SITE, SEE PRIOR. K. ATYPICAL DUCTAL EPITHELIAL HYPERPLASIA. L. FIBROADENOMA AND FIBROADENOMATOID NODULAR CHANGES. M. FIBROCYSTIC CHANGES WITH COLUMNAR CELL CHANGES, DUCTAL EPITHELIAL HYPERPLASIA AND. ASSOCIATED MICROCALCIFICATIONS. N. MICROSCOPIC CAPILLARY HEMANGIOMA. O. MEDIAL CALCIFICATION OF BLOOD VESSEL. P. IMMUNOHISTOCHEMICAL STAINING FOR ESTROGEN RECEPTOR, PROGESTERONE RECEPTOR AND HER-. 2/NEU ARE BEING PERFORMED ON PREVIOUS SPECIMEN. AND RESULTS ARE PENDING. COMMENT: Part 2: The above measurement of the micrometastatic tumor within the lymph node is made on the slide. The. original frozen section slide was re-reviewed with Dr. and there was no diagnostic changes identified. Part 3: Immunohistochemical staining for e-cadherin/p120, support the ductal phenotype of the carcinoma in situ.

expanded version (tokens=1049) : 
 The breast pathology report reveals the following information:

1. Histological classification: Infiltrating ductal carcinoma (IDC) with ductal carcinoma in-situ (DCIS) subtype LumB
2. Tumor size: 2.7 x 2.5 x 2.4 cm
3. Histological grade: Nottingham score of 9 out of 9 (Tubules-3, Nuclear-3, Mitoses-3)
4. Necrosis: Comedonecrosis is present in the DCIS component
5. Tumor infiltrating lymphocytes: There is no mention of tumor infiltrating lymphocytes
6. Lymphovascular invasion: Extensive lymphovascular invasion is present
7. Calcification: Microcalcifications are associated with the DCIS component and fibrocystic changes
8. Receptor status: Immunohistochemical staining for estrogen receptor, progesterone receptor and HER2/neu is being performed, and results are pending
9. Ancillary testing results: Immunohistochemical staining for e-cadherin/p120 supports the ductal phenotype of the carcinoma in situ.

It is important to note that there is also a report of lymph node biopsy and frozen sections, revealing one lymph node free of tumor and another with micrometastatic adenocarcinoma involving one out of two lymph nodes. The original frozen section slide was re-reviewed, and there were no diagnostic changes identified. Additionally,

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1239) : 
 The breast pathology report reveals infiltrating ductal carcinoma (IDC) with ductal carcinoma in-situ (DCIS) subtype LumB. The tumor measures 2.7 x 2.5 x 2.4 cm and has a Nottingham score of 9/9. Comedonecrosis is present in the DCIS component, extensive lymphovascular invasion is noted, calcifications are associated with DCIS component and fibrocystic changes, and pending results exist for immunohistochemical staining for estrogen receptor, progesterone receptor and HER2/neu. Immunohistochemical staining for e-cadherin/p120 supports the ductal phenotype of the carcinoma in situ.

